Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy

被引：0
|
作者：
Youngjoo Lee
Sun Hye Kim
Ji-Youn Han
Heung Tae Kim
Tak Yun
Jin Soo Lee
机构：
[1] National Cancer Center,Center for Lung Cancer
[2] National Cancer Center,Center for Clinical Trials
来源：
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词：
Adenocarcinoma; Gefitinib; Lymphocyte; Neutrophil; Non-small-cell lung cancer; Prognostic marker; Predictive marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2009 / 2016
页数：7
相关论文
共 50 条
  • [21] High Neutrophil-to-lymphocyte Ratio Persistent During First-line Chemotherapy Predicts Poor Clinical Outcome in Patients with Advanced Urothelial Cancer
    Rossi, Lorena
    Santoni, Matteo
    Crabb, Simon J.
    Scarpi, Emanuela
    Burattini, Luciano
    Chau, Caroline
    Bianchi, Emanuela
    Savini, Agnese
    Burgio, Salvatore L.
    Conti, Alessandro
    Conteduca, Vincenza
    Cascinu, Stefano
    De Giorgi, Ugo
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (04) : 1377 - 1384
  • [22] Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib
    Wu, Kuan-Li
    Tsai, Ming-Ju
    Yang, Chih-Jen
    Chang, Wei-An
    Hung, Jen-Yu
    Yen, Chun-Ju
    Shen, Chi-Hsiang
    Kuo, Tzu-Yu
    Lee, Jui-Ying
    Chou, Shah-Hwa
    Liu, Ta-Chih
    Chong, Inn-Wen
    Huang, Ming-Shyan
    [J]. LUNG CANCER, 2015, 88 (02) : 187 - 194
  • [23] The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib
    Chen, Kuan-Chih
    Huang, Yen-Hsiang
    Hsu, Kuo-Hsuan
    Tseng, Jeng-Sen
    Chang, Gee-Chen
    Yang, Tsung-Ying
    [J]. ONCOTARGETS AND THERAPY, 2023, 16 : 317 - 326
  • [24] Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
    Yanwen Yao
    Dongmei Yuan
    Hongbing Liu
    Xiaoling Gu
    Yong Song
    [J]. Cancer Immunology, Immunotherapy, 2013, 62 : 471 - 479
  • [25] Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy
    Yao, Yanwen
    Yuan, Dongmei
    Liu, Hongbing
    Gu, Xiaoling
    Song, Yong
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (03) : 471 - 479
  • [26] Association of XRCC1 Arg399GIn polymorphism with tumor response and survival in never-smokers with advanced lung adenocarcinoma treated with gefitinib as the first-line therapy
    Han, Ji-Youn
    Yoon, Kyong-Ah
    Park, Jae Hee
    Yoon, Sung Jin
    Han, Jong Hee
    Lee, Jin Soo
    [J]. CANCER RESEARCH, 2009, 69
  • [27] Association of XRCC1 Arg399Gln polymorphism with tumor response and survival in never-smokers with advanced lung adenocarcinoma treated with gefitinib as the first-line therapy
    Han, Ji-Youn
    Yoon, Kyong-Ah
    Park, Jae Hee
    Yoon, Sung Jin
    Han, Jong Hee
    Lee, Jin Soo
    [J]. CANCER RESEARCH, 2009, 69
  • [28] Prognostic role of neutrophil-to-lymphocyte ratio (NLR) dynamics during first-line FOLFOXIRI in advanced pancreatic cancer (aPC).
    Pecora, Irene
    Musettini, Gianna
    Catanese, Silvia
    Vivaldi, Caterina
    Pasquini, Giulia
    Caparello, Chiara
    Lencioni, Monica
    Falcone, Alfredo
    Fornaro, Lorenzo
    Vasile, Enrico
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Prognostic Impact of KRAS Mutational Status in Patients with Advanced Lung Adenocarcinoma Receiving First-Line Cytotoxic Chemotherapy
    Desai, Arpita
    He, Xiangyun
    Gandhi, Shipra
    Wang, Chong
    Meagher, Alison
    Dy, Grace K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S421 - S421
  • [30] Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy
    Park, Yong Hyun
    Ku, Ja Hyeon
    Kwak, Cheol
    Kim, Hyeon Hoe
    [J]. SPRINGERPLUS, 2014, 3 : 1 - 6
12345